Preparation and application of a multi-component complex coagulant based on glutenin
By using a composite coagulant preparation method of glutenin, ε-PL and tannic acid, the problem of low gas barrier performance of glutenin coating was solved, achieving better antioxidant and antibacterial effects and expanding its application in food preservation.
Patent Information
- Application Number
- CN202411184259.6
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-27
- Publication Date
- 2026-11-17
- Estimated Expiration
- 2044-08-27
AI Technical Summary
Existing glutenin-based edible coatings have low gas barrier performance in food preservation and lack antibacterial and antioxidant properties, which limits their practical application.
An edible coating was prepared by forming a multi-component composite aggregate of glutenin/ε-polylysine/tannic acid, combined with different mass ratios of glutenin, ε-PL and tannic acid. This process retained the antibacterial activity of ε-PL and the antioxidant activity of tannic acid, thereby improving the gas barrier performance of the coating.
It significantly improves the water vapor and oxygen barrier properties of glutenin coatings, enhances antioxidant and antibacterial effects, and broadens the application scenarios of glutenin coatings.
Smart Images

Figure CN119081552B_ABST
Abstract
Description
Technical Field
[0001] This invention relates to the preparation and application of a multi-component composite coagulant based on glutenin, belonging to the field of food packaging. Background Technology
[0002] Microbial contamination is a major cause of food quality deterioration, and how to inhibit or slow down microbial growth and metabolic activity during food preservation is a current research hotspot both domestically and internationally. Unlike traditional food packaging materials, edible coatings or films are thin layers wrapped or covered on the surface of food, designed to prevent the migration of moisture, gases, and solutes between food and the environment. Compared to polysaccharide or lipid-based coatings and films, protein-based edible coatings have attracted increasing attention due to their low cost, wide availability, high nutritional value, better gas barrier properties, and mechanical properties. Therefore, the development of novel protein-based edible coatings is of great significance.
[0003] Currently, domestic and international research largely focuses on using polysaccharides for food coating and preservation. However, protein-based coatings possess advantages such as high nutritional value, good taste, and low permeability, making the development of novel protein-based edible coatings necessary. Major raw materials extensively studied include gelatin, soy protein, zein, and whey protein. Different protein coatings exhibit varying film-forming properties and gas barrier performance. Furthermore, factors such as color, taste, and allergens can limit consumer purchasing desire; therefore, research into other types of proteins is essential.
[0004] Glutenin is an abundant protein in wheat gluten (approximately 30%-40%), composed of polypeptide chains linked by intermolecular disulfide bonds. The molecule exhibits a fibrous structure, is elongated, and has a large surface area, possessing numerous active groups that readily interact with other molecules. The amino acid composition of glutenin indicates that its central repeating region is hydrophilic, while its N- and C-terminal regions are hydrophobic. This amphiphilic molecular characteristic allows glutenin to assemble with other molecules into nanoscale structures. Compared to other proteins, glutenin is widely available, odorless, has a low risk of allergies, strong film-forming ability, and good uniformity, making it suitable as a substrate for edible coatings. However, glutenin edible coatings suffer from limited functional properties and low gas barrier performance, restricting their practical applications. Edible coatings in food preservation primarily focus on antibacterial effects, antioxidant properties, gas barrier performance, and physical properties (thickness, transparency, uniformity). Therefore, it is necessary to add other substances to glutenin coatings to enhance their basic properties while imparting new functions, thereby improving preservation effects. Composite aggregates are one of the most effective encapsulation technologies, known for their simplicity, low cost, scalability, and reproducibility of functional components, but there is currently limited research on glutenin.
[0005] Therefore, the preparation of an edible coating with good antibacterial, gas barrier, and antioxidant properties based on the film-forming properties of glutenin combined with a composite gel method has high practical and economic value. Summary of the Invention
[0006] To address at least one of the aforementioned problems and improve the effectiveness of glutenin in practical applications, this patent proposes a method for forming a composite coagulant based on glutenin, ε-polylysine (ε-PL), and tannic acid. This method can effectively retain the antibacterial activity of ε-PL and the antioxidant activity of tannic acid, and can also improve the water permeability and air permeability of the glutenin coating, with the aim of improving the performance of packaging materials and extending the shelf life of food.
[0007] To address the shortcomings of existing technologies, this invention first forms a composite coagulant from glutenin and ε-PL, then adds tannic acid to obtain a glutenin / ε-PL / tannic acid multi-component composite coagulant. By analyzing the bactericidal and antioxidant properties of this multi-component composite coagulant at different mass ratios, a composite coagulant that retains the bioactivity of ε-PL and tannic acid and possesses excellent bactericidal and antioxidant properties is obtained. After natural drying, this composite coagulant forms an edible coating on a substrate surface. Analysis of the water vapor permeability and oxygen permeability of this edible coating reveals that the coating prepared from the glutenin / ε-PL / tannic acid multi-component composite coagulant significantly improves the water vapor and oxygen barrier properties of a single glutenin coating. This invention is simple to operate, uses inexpensive raw materials, has outstanding effects, and is widely applicable, further expanding the application of glutenin edible coatings.
[0008] The first objective of this invention is to provide a multi-component composite coagulant coating based on glutenin, wherein the preparation method of the multi-component composite coagulant coating based on glutenin is as follows:
[0009] The substrate was immersed in a multi-component composite coagulant solution of glutenin / ε-polylysine / tannic acid to prepare a multi-component composite coagulant coating on the surface of the substrate.
[0010] The preparation method of the glutenin / ε-polylysine / tannic acid multi-component composite coagulate solution includes the following steps:
[0011] (1) Mix glutenin solution with ε-polylysine solution to obtain glutenin / ε-PL two-component composite coagulate solution; wherein the mass ratio of glutenin to ε-polylysine is 1 to 5:1;
[0012] (2) Take the glutenin / ε-PL two-component composite coagulation solution and add tannic acid solution under stirring conditions of 300-400 rpm to prepare a glutenin / ε-polylysine / tannic acid multi-component composite coagulation solution; wherein the mass ratio of tannic acid to ε-polylysine is 1:9-47.
[0013] In one embodiment, the substrate includes, but is not limited to, common solid or semi-solid materials such as films, plastics, metals, and stone.
[0014] In one embodiment, the substrate is immersed in a multi-component composite coagulant solution of glutenin / ε-polylysine / tannic acid for at least 20 minutes.
[0015] In one embodiment, the method for preparing the glutenin solution includes:
[0016] Dissolve glutenin in 0.01–0.05 M NaOH solution at a ratio of 0.4–1 g: 50 mL, and stir at 400–600 rpm for 20–40 min. Add an equal volume of PBS buffer and continue stirring for 1–3 h. After stirring, centrifuge at 4000–5000 rpm for 10–20 min, collect the supernatant, and prepare the glutenin solution.
[0017] In one embodiment, the pH of the glutenin solution is 7–9.
[0018] In one embodiment, the pH of the ε-polylysine solution is 6 to 8.
[0019] In one embodiment, the pH of the tannic acid solution is 6 to 7.
[0020] In one embodiment, the mass ratio of glutenin to ε-PL is 1 to 5, wherein the final concentration of glutenin is 1 to 20 mg / mL and the final concentration of ε-PL is 1 to 10 mg / mL.
[0021] In one embodiment, the method of adding tannic acid includes dripping, stirring, and mixing, wherein the final concentration of tannic acid is 0.085–0.425 mg / mL.
[0022] In one embodiment, the preparation method includes the following steps:
[0023] (1) Preparation of solutions of glutenin, ε-PL and tannic acid:
[0024] Add 0.4 g of glutenin to 50 mL of NaOH solution (0.01 M) and stir at 500 rpm for 30 min. Then add 50 mL of PBS buffer (0.1 mM, pH 7.4) and continue stirring for 1 h. After stirring, centrifuge at 5000 rpm for 10 min, collect the supernatant to obtain the glutenin solution, and store it at 4℃ for later use.
[0025] ε-PL solid powder was dissolved in deionized water to obtain an ε-PL solution of a certain concentration. After filtration, the solution was stored in a refrigerator at 4°C for later use.
[0026] Tannic acid solid powder is dissolved in deionized water to obtain a tannic acid solution of a certain concentration, which should be prepared and used immediately.
[0027] (2) Preparation of multi-component complex coagulant of glutenin / ε-PL / tannic acid
[0028] First, ε-PL solution and glutenin solution are mixed at a volume ratio of 1:1 to obtain glutenin / ε-PL two-component composite coagulation. Then, a certain concentration of tannic acid solution is added to it to obtain glutenin / ε-PL / tannic acid multi-component composite coagulation solution.
[0029] In one embodiment, the mass ratio of glutenin to ε-PL in the complex aggregate of step (1) is 1 to 4.
[0030] In one embodiment, the mass ratio of glutenin, ε-PL and tannic acid in the multi-component complex aggregate of glutenin / ε-PL / tannic acid in step (1) is 20:5:0.425.
[0031] A second objective of this invention is to provide a multi-component complex coagulant based on glutenin, wherein the multi-component complex coagulant is prepared from glutenin, ε-polylysine, and tannic acid, and the preparation method includes:
[0032] (1) Mix glutenin solution with ε-polylysine solution to obtain glutenin / ε-PL two-component composite coagulate solution; wherein the mass ratio of glutenin to ε-polylysine is 1 to 5:1;
[0033] (2) Take the glutenin / ε-PL two-component composite coagulation solution and add tannic acid solution under stirring conditions of 300-400 rpm to prepare a multi-component composite coagulation based on glutenin; wherein the mass ratio of tannic acid to ε-polylysine is 1:9-47.
[0034] In one embodiment, the method for preparing the glutenin solution includes:
[0035] Dissolve glutenin in 0.01–0.05 M NaOH solution at a ratio of 0.4 g: 50 mL, and stir at 400–600 rpm for 20–40 min. Add an equal volume of PBS buffer and continue stirring for 1–3 h. After stirring, centrifuge at 4000–5000 rpm for 10–20 min, collect the supernatant, and prepare the glutenin solution.
[0036] In one embodiment, the pH of the glutenin solution is 7–9.
[0037] In one embodiment, the pH of the ε-polylysine solution is 6 to 8.
[0038] In one embodiment, the pH of the tannic acid solution is 6 to 7.
[0039] In one embodiment, the mass ratio of glutenin to ε-PL is 1 to 5, wherein the final concentration of glutenin is 1 to 20 mg / mL and the final concentration of ε-PL is 1 to 10 mg / mL.
[0040] In one embodiment, the method of adding tannic acid includes dripping, stirring, and mixing, wherein the final concentration of tannic acid is 0.085–0.425 mg / mL.
[0041] In one embodiment, the preparation method includes the following steps:
[0042] (1) Preparation of solutions of glutenin, ε-PL and tannic acid:
[0043] Add 0.4 g of glutenin to 50 mL of NaOH solution (0.01 M) and stir at 500 rpm for 30 min. Then add 50 mL of PBS buffer (0.1 mM, pH 7.4) and continue stirring for 1 h. After stirring, centrifuge at 5000 rpm for 10 min, collect the supernatant to obtain the glutenin solution, and store it at 4℃ for later use.
[0044] ε-PL solid powder was dissolved in deionized water to obtain an ε-PL solution of a certain concentration. After filtration, the solution was stored in a refrigerator at 4°C for later use.
[0045] Tannic acid solid powder is dissolved in deionized water to obtain a tannic acid solution of a certain concentration, which should be prepared and used immediately.
[0046] (2) Preparation of multi-component complex coagulant of glutenin / ε-PL / tannic acid
[0047] First, ε-PL solution and glutenin solution are mixed at a volume ratio of 1:1 to obtain glutenin / ε-PL two-component composite coagulation. Then, a certain concentration of tannic acid solution is added to it to obtain glutenin / ε-PL / tannic acid multi-component composite coagulation solution.
[0048] In one embodiment, the mass ratio of glutenin to ε-PL in the complex aggregate of step (1) is 1-4;
[0049] In one embodiment, the mass ratio of glutenin, ε-PL and tannic acid in the multi-component complex aggregate of glutenin / ε-PL / tannic acid in step (1) is 20:5:0.425.
[0050] A third object of the present invention is to provide a product comprising one or more of the above-mentioned multi-component composite coagulant coating based on glutenin or any of the above-mentioned multi-component composite coagulants based on glutenin; the product includes chemical products, packaging materials or food preservation products.
[0051] In one embodiment, the chemical products include: paints, fuels, coatings, pigments, reagents, additives, adhesives, etc.
[0052] In one embodiment, the packaging material includes: polyethylene terephthalate, polystyrene, polyethylene, polyvinyl chloride, phenolic resin, urea-formaldehyde resin, epoxy resin, polyester, polyurethane, polymethyl methacrylate, etc.
[0053] A fourth object of the present invention is to provide the application of any of the above-mentioned glutenin-based multi-component composite coagulant coatings or any of the above-mentioned glutenin-based multi-component composite coagulants in the preparation of products, including chemical products, packaging materials or food preservation products.
[0054] In one embodiment, the chemical products include: paints, fuels, coatings, pigments, reagents, additives, and adhesives; the packaging materials include: polyethylene terephthalate, polystyrene, polyethylene, polyvinyl chloride, phenolic resin, urea-formaldehyde resin, epoxy resin, polyester, polyurethane, polymethyl methacrylate, etc.
[0055] In one embodiment, a multi-component composite coagulant coating based on glutenin can be used to prepare food preservation materials or package food; the food includes any one of meat, eggs, fruit, fresh-cut fruit, etc.
[0056] The beneficial effects of this invention are:
[0057] This invention combines glutenin, ε-PL, and tannic acid. By controlling the mass ratio and order of addition, a multi-component composite coagulant can be obtained, which excellently retains the antibacterial properties of ε-PL and the antioxidant properties of tannic acid, and delays the oxidation time of tannic acid by air. Furthermore, this composite coagulant can form an edible coating on packaging materials and food surfaces, significantly improving its ability to block water vapor and oxygen permeability compared to a single glutenin coating. This invention fills a gap in the application of glutenin and further broadens the application of glutenin, ε-PL, and tannic acid in the food industry.
[0058] Specifically:
[0059] (1) The multi-component composite coagulate of glutenin / ε-PL / tannic acid of the present invention has significant antioxidant effect;
[0060] (2) The multi-component composite coagulant of glutenin / ε-PL / tannic acid of the present invention has excellent antibacterial effect and can maintain 100% sterilization rate even after 8 hours.
[0061] (3) The glutenin / ε-PL / tannic acid multi-component composite coagulant of the present invention, after being coated, can significantly improve the permeability of water vapor and oxygen, by 21.13% and 8.45% respectively compared with PET film. Attached Figure Description
[0062] Figure 1 Images of glutenin / ε-PL complex aggregates at different mass ratios (MR refers to the mass ratio of glutenin to ε-PL, with the ratio value indicated in the lower right corner; MR0 to MR5 correspond to Example 1; MR... 5.5 ~MR 20 Response ratio 1);
[0063] Figure 2 The turbidity of the glutenin / ε-PL complex coagulates at different mass ratios (MR refers to the mass ratio of glutenin to ε-PL, with the subscript indicating the ratio value; where MR0 to MR5 correspond to Example 1; MR 5.5 ~MR 20 Response ratio 1);
[0064] Figure 3 The image shows the glutenin / tannic acid complex system of Comparative Example 2 after standing at 23°C for 5 minutes (MR refers to the mass ratio of glutenin to tannic acid, and the lower right corner indicates the ratio value).
[0065] Figure 4 The image shows the glutenin / tannic acid / ε-PL complex system of Comparative Example 2 after standing at 23°C for 5 minutes (MR represents the mass ratio; glutenin:ε-PL). The final concentration of tannic acid was fixed at 0.425 mg / mL.
[0066] Figure 5 Example 1 is a glutenin / ε-PL / tannic acid complex coagulated with a final concentration of glutenin of 20 mg / mL, a final concentration of ε-PL of 4 mg / mL, and a final concentration of tannic acid of 0.425 mg / mL.
[0067] Figure 6 The results of the antibacterial and bactericidal experiments of the glutenin / ε-PL / tannic acid complex in Example 1 are as follows: (A) Total number of Escherichia coli colonies after treatment with the glutenin / ε-PL complex; (B) Total number of Staphylococcus aureus colonies after treatment with the glutenin / ε-PL complex; (C) Bactericidal rate of the glutenin / ε-PL / tannic acid complex against Escherichia coli and Staphylococcus aureus (with a fixed final ε-PL concentration of 4 mg / mL).
[0068] Figure 7 The DPPH free radical scavenging rate of the glutenin / ε-PL / tannic acid complex and tannic acid in Example 1 (MR is the mass ratio; glutenin:tannic acid, wherein the final concentration of glutenin was fixed at 20 mg / mL);
[0069] Figure 8 The water vapor and oxygen permeability of glutenin / ε-PL / tannic acid composite coagulated coatings prepared by different methods are shown, with the final concentration of glutenin being 20 mg / mL, the final concentration of ε-PL being 5 mg / mL, and the final concentration of tannic acid being 0.425 mg / mL. Detailed Implementation
[0070] The preferred embodiments of the present invention are described below. It should be understood that the embodiments are for better explanation of the present invention and are not intended to limit the present invention.
[0071] The instruments involved in this invention:
[0072] UV-Vis spectrophotometer (Model T 9, Beijing Purkinje General Instrument Co., Ltd.); Controllable constant temperature and humidity test chamber (Dongguan Huitai Machinery Co., Ltd.); Handheld digital micrometer (Mitutoyo S.p.A., Spain); Gas permeation testing system C130H (Jinan Langguang Electromechanical Technology Co., Ltd.)
[0073] Raw material source:
[0074] ε-PL was purchased from Zhangshu Lion King Biotechnology Co., Ltd.; tannic acid and glutenin were purchased from Shanghai Aladdin Biochemical Technology Co., Ltd.; and PET film was purchased from Dongguan Jubang Plastic Materials Co., Ltd.
[0075] The test methods involved in the embodiments and comparative examples of this invention are as follows:
[0076] 1. The effect of different mass ratios on the composite aggregate system:
[0077] Using an ultraviolet spectrophotometer (OD) 600 The turbidity of the complex coagulated by glutenin and ε-PL was compared. The measurements were performed three times in parallel, and the average value was taken. The stability of the complex coagulated was analyzed by comparing the turbidity before and after standing for 30 minutes.
[0078] 2. Determination of minimum bactericidal concentration (MBC):
[0079] First, add 100 μL of LB broth medium to each well of a 96-well plate. Then, add 100 μL of the prepared ε-PL or glutenin / ε-PL complex at different concentrations to the first well of each row. Mix thoroughly with a pipette, then add 100 μL to the second well. Repeat this process up to well 11. Discard the 100 μL after each addition. Each sample group is repeated three times. Well 12 serves as a blank control group. Add 100 μL of diluted bacterial suspension (concentration 10) to wells 1-11. 6 (CFU / mL). Incubate the 96-well plate in a constant temperature incubator (37℃) for 24 hours. After incubation, use a pipette to inoculate 100 μL of bacterial suspension onto a plate counting agar, spreading it evenly. Incubate for 16 hours. If no colonies grow in the culture medium, it indicates that the antimicrobial agent at this concentration has a bactericidal effect on microorganisms; otherwise, it indicates that the antimicrobial agent at this concentration only has an inhibitory effect on microorganisms.
[0080] 3. Determination of bactericidal kinetics:
[0081] Bacteria in the logarithmic growth phase (Escherichia coli and Staphylococcus aureus) were resuspended twice in PBS (0.1 mM), and then diluted to 10⁻⁶ with PBS buffer. 6 CFU / mL. An equal volume of diluted bacterial suspension was mixed with the composite coagulant. An equal volume of diluted bacterial suspension mixed with ε-PL served as a control. The final concentration of ε-PL was fixed at 1 mg / mL. The mass ratio of glutenin to ε-PL in the composite coagulant was 0 mg / mL, 0.5 mg / mL, 2 mg / mL, 5 mg / mL, 10 mg / mL, and 20 mg / mL. Sterile PBS buffer served as the control group. Subsequently, the test tubes were placed in a microbial shaker (37℃, 150 rpm) for incubation. The total colony count was measured at regular time points, and bactericidal kinetic curves were plotted.
[0082] 4. DPPH free radical scavenging experiment:
[0083] Combine 2 mL of DPPH solution (prepared with 0.1 mM ethanol) with 2 mL of water to form A. cThe sample was diluted 50 times to obtain a sample solution. 2 mL of DPPH solution was combined with 2 mL of the sample solution to form solution A. t Combine 2 mL of sample solution with 2 mL of water to form A. b After standing at 25℃ in the dark for 30 minutes, the absorbance was measured at 517 nm. The free radical scavenging rate was calculated as follows:
[0084]
[0085] 5. Preparation of coated PET film:
[0086] PET (0.07 mm thick) was sequentially immersed in acetone, ethanol, and deionized water, and then ultrasonically treated for 20 min. After natural drying, a clean PET membrane was obtained. Three types of PET membranes were prepared: PET membranes were immersed in glutenin (20 mg / mL), PET membranes were immersed in a glutenin / ε-PL (glutenin 20 mg / mL, ε-PL 4 mg / mL) two-component composite coagulation, and PET membranes were immersed in a glutenin / ε-PL / tannic acid multi-component composite coagulation coating (glutenin 20 mg / mL, ε-PL 4 mg / mL, tannic acid 0.425 mg / mL) for 30 min. After removal and natural air drying, they were stored in a desiccator.
[0087] 6. Determination of water vapor transmission rate:
[0088] Water vapor permeation was determined by gravimetric method. A permeation cup (30mm×50mm weighing bottle) containing 10mL of deionized water was sealed with the coated PET film treated in step 5. The initial weight was recorded and the cup was placed in a desiccator. The weight of the permeation cup was measured every 12 hours for a total of 6 days.
[0089] 7. Determination of oxygen permeability:
[0090] The oxygen permeability of the coated PET film after step 5 treatment was determined using a gas permeation test system in an environment of 23°C and 50% humidity.
[0091] Example 1: Preparation of glutenin / ε-PL / tannic acid complex coagulates
[0092] 1. Preparation of glutenin / ε-PL two-component composite coagulates
[0093] (1) Take 0.4 g of glutenin and add it to 50 mL of NaOH solution (0.01 M). Stir at 500 rpm for 30 min, then add 50 mL of PBS buffer (0.1 mM, pH 7.4) and continue stirring for 1 h. After stirring, centrifuge at 5000 rpm for 10 min, take the supernatant to obtain the glutenin solution and store it at 4℃ for later use. Dissolve ε-PL solid powder in PBS buffer to obtain a 10 mg / mL ε-PL solution, filter and store it at 4℃ for later use. Dissolve tannic acid powder in deionized water to obtain a 0.85 mg / mL tannic acid solution.
[0094] (2) Take the glutenin solution obtained in step (1) and the ε-PL solution and mix them at a mass ratio of 1 to 20 (glutenin: ε-PL, where the concentration of ε-PL is fixed at 250 μg / mL) to prepare a glutenin / ε-PL two-component composite coagulation solution.
[0095] 2. Testing the antibacterial properties of glutenin / ε-PL two-component composite coagulant solution
[0096] The minimum bactericidal concentration (MBC) of the glutenin / ε-PL two-component complex coagulant solution was determined, and the results are shown in Table 1.
[0097] The results showed that the minimum bactericidal concentration of the glutenin / ε-PL two-component complex coagulation solution against Escherichia coli and Staphylococcus aureus was 1000 μg / mL.
[0098] Table 1 Minimum Bacterial Composition Concentration (MBC)
[0099] E. coli Staphylococcus aureus MBC (μg / mL) MBC (μg / mL) ε-PL 1000 1000 <![CDATA[MR1]]> 1000 1000 <![CDATA[MR2]]> 1000 1000 <![CDATA[MR5]]> 1000 1000 <![CDATA[MR 10 ]]> 1000 1000 <![CDATA[MR 20 ]]> 1000 1000
[0100] 3. A multi-component complex coagulant based on glutenin, comprising the following steps:
[0101] (1) Take 0.4 g of glutenin and add it to 50 mL of NaOH solution (0.01 M). Stir at 500 rpm for 30 min, then add 50 mL of PBS buffer (0.1 mM, pH 7.4) and continue stirring for 1 h. After stirring, centrifuge at 5000 rpm for 10 min, take the supernatant to obtain the glutenin solution and store it at 4℃ for later use. Dissolve ε-PL solid powder in PBS buffer to obtain a 10 mg / mL ε-PL solution, filter and store it at 4℃ for later use. Dissolve tannic acid powder in deionized water to obtain a 0.85 mg / mL tannic acid solution.
[0102] (2) Take the glutenin solution obtained in step (1) and the ε-PL solution and mix them at a mass ratio of 1 to 5 (glutenin: ε-PL, where the ε-PL concentration is fixed at 4 mg / mL) to obtain a glutenin / ε-PL two-component composite coagulation solution.
[0103] (3) Take the glutenin / ε-PL two-component composite coagulant obtained in step (2), add tannic acid solution under stirring at 300 rpm to make the final concentration of tannic acid 0.425 mg / mL, and prepare glutenin / ε-PL / tannic acid multi-component composite coagulant solution.
[0104] 4. Performance Testing
[0105] (1) Turbidity detection of glutenin / ε-PL two-component composite coagulated solution
[0106] Take the glutenin / ε-PL two-component composite coagulation solutions with different mass ratios (MR0~MR5) prepared above, let them stand at 23℃ for 30 min, and observe with the naked eye and measure the turbidity of the solution. If there is no significant decrease, it is considered to be a stable system.
[0107] The turbidity results of the glutenin / ε-PL two-component complex coagulated solution are as follows: Figure 1 As shown (MR0~MR5, MR represents the mass ratio of glutenin to ε-PL); OD of glutenin / ε-PL bicomponent complex coagulations 600 (MR0~MR5, MR represents the mass ratio of glutenin to ε-PL) For example Figure 2 As shown.
[0108] Depend on Figure 1 and Figure 2 It can be seen that within the mass ratio of glutenin to ε-PL of 1 to 5, no obvious precipitation was observed by the naked eye, and the OD... 600 The turbidity did not decrease, indicating that stable complex aggregates can be formed.
[0109] (2) Detection of tannic acid oxidation by multi-component complex flocculant solution of glutenin / ε-PL / tannic acid.
[0110] The multi-component complex coagulant solution of glutenin / ε-PL / tannic acid prepared by the above method (final concentration of glutenin: 20 mg / mL; final concentration of ε-PL: 5 mg / mL; final concentration of tannic acid: 0.425 mg / mL) did not separate into layers after standing at 23℃ for 30 min. The results are as follows. Figure 5 As shown, the solution color did not change significantly, indicating that the composite coagulant can effectively slow down the oxidation of tannic acid by air.
[0111] (3) Antibacterial performance test of glutenin / ε-PL two-component composite coagulant solution: Glutenin / ε-PL composite coagulants were prepared according to method 1 (glutenin to ε-PL mass ratio of 0.5–20; ε-PL concentration of 4 mg / mL). Their bactericidal kinetics (Escherichia coli, Staphylococcus aureus) were tested, with ε-PL (concentration of 4 mg / mL) as a control. The results are as follows: Figure 6 A, 6B, Table 2, and Table 3 are shown.
[0112] The results showed that the glutenin / ε-PL composite coagulant had effective bactericidal properties, and the antibacterial properties of ε-PL in the composite coagulant were not reduced even after treatment for more than 8 hours.
[0113] (4) Antibacterial properties of glutenin / ε-PL / tannic acid complex coagulation were tested.
[0114] A glutenin / ε-PL / tannic acid complex coagulated with a glutenin:tannic acid mass ratio of 47–235 and a fixed ε-PL concentration of 4 mg / mL was prepared according to method 1. Its bactericidal kinetics (Escherichia coli and Staphylococcus aureus) were tested. ε-PL (concentration 4 mg / mL) and the glutenin / ε-PL complex coagulated with glutenin (20 mg / mL; ε-PL 4 mg / mL) were used as controls. The results are as follows: Figure 6 C. As shown in Table 4.
[0115] The results showed that the glutenin / ε-PL / tannic acid composite coagulate could still maintain the good bactericidal properties of the glutenin / ε-PL / tannic acid multi-component composite coagulate after the addition of tannic acid, and could still maintain a 100% bactericidal rate after 8 hours of treatment with bacterial solution.
[0116] Table 2. Inhibitory effect of glutenin / ε-PL two-component composite coagulant solution on Escherichia coli
[0117]
[0118]
[0119] Table 3. Inhibitory effect of glutenin / ε-PL two-component composite coagulant solution on Staphylococcus aureus
[0120]
[0121] Table 4. Antibacterial effect of multi-component complex coagulant containing glutenin / ε-PL / tannins
[0122]
[0123] (5) Antioxidant properties of glutenin / ε-PL / tannic acid complex
[0124] A glutenin / ε-PL / tannic acid complex coagulated with a glutenin:tannic acid mass ratio of 47–235 and a final glutenin concentration of 20 mg / mL was prepared according to method 1. Glutenin-only (20 mg / mL) and the glutenin / ε-PL complex coagulated with 20 mg / mL glutenin and 1 mg / mL ε-PL were used as controls. The results are as follows: Figure 7 As shown.
[0125] The results showed that glutenin and ε-PL did not have the ability to scavenge DPPH free radicals, but after forming a multi-component complex of glutenin / ε-PL / tannic acid, it was able to retain almost the DPPH free radical scavenging effect of tannic acid itself.
[0126] In summary, the multi-component complex coagulated by glutenin / ε-PL / tannic acid can fully retain the antibacterial properties of ε-PL and the antioxidant properties of tannic acid, and delays the oxidation of tannic acid by air.
[0127] Comparative Example 1: Changing the dosage of ε-PL
[0128] Based on Example 1 (other steps and parameters are the same as in Example 1), the mass ratio of glutenin to ε-PL in step (2) is adjusted to 6 to 20 (glutenin: ε-PL, where the final concentration of ε-PL is fixed at 1 mg / mL) to prepare glutenin / ε-PL composite coagulants and glutenin / ε-PL / tannic acid multi-component composite coagulants, respectively.
[0129] The results are as follows Figure 1 and Figure 2 As shown, the results indicate that the glutenin / ε-PL complex coagulate (glutenin to ε-PL mass ratio of 6–20) exhibits obvious stratification after standing at 23℃ for 30 min, as shown in the figure. Figure 1 and Figure 2 As shown, and OD 600 The turbidity was significantly reduced, indicating that the multi-component complex coagulated system of glutenin / ε-PL / tannic acid was unstable.
[0130] Comparative Example 2: Changing the preparation order
[0131] Based on Example 1 (other unmentioned steps and parameters are the same as in Example 1), the order of adding raw materials is adjusted, that is, the glutenin solution and tannic acid solution are mixed first, and then the ε-PL solution is added. Specifically, the steps are as follows:
[0132] Mix glutenin solution with tannic acid solution (final glutenin concentration of 20 mg / mL, final tannic acid concentration range of 0.085–0.425 mg / mL) to form glutenin / tannic acid complex system.
[0133] The results are as follows Figure 3 As shown, the composite system showed stratification after standing at 23°C for 30 minutes, and the tannins were oxidized to yellow, indicating that tannins cannot form a stable composite system with glutenin.
[0134] Considering that ε-PL might affect the system, ε-PL solution was then added to the glutenin / tannic acid complex system (with a fixed tannic acid concentration of 0.425 mg / mL and glutenin concentration of 20 mg / mL) to make the glutenin to ε-PL mass ratio 4 to 20. Under stirring at 300 rpm, a multi-component complex system of glutenin / tannic acid / ε-PL with a tannic acid concentration of 0.425 mg / mL and different glutenin to ε-PL ratios was obtained.
[0135] The results are as follows Figure 4 As shown, the multi-component composite system exhibited obvious stratification after standing at 23℃ for 30 min, indicating that the subsequent addition of ε-PL could not improve the stability of the glutenin / tannic acid composite system.
[0136] Example 2: Preparation of glutenin / ε-PL / tannic acid composite coagulated coating
[0137] The preparation method of an edible coating based on a multi-component composite coagulant of glutenin is as follows:
[0138] (1) Based on Example 1, a multi-component complex coagulated by glutenin / ε-PL / tannic acid was prepared (wherein, the concentrations were: glutenin concentration of 20 mg / mL; ε-PL concentration of 4 mg / mL; and tannic acid concentration of 0.425 mg / mL).
[0139] (2) The PET (thickness 0.07 mm) was sequentially immersed in acetone, ethanol and deionized water, and ultrasonically treated for 20 min. After natural drying, a clean PET film was obtained. Then the PET film was immersed in the above-mentioned glutenin / ε-PL / tannic acid multi-component composite coagulant for 30 min. After removal, it was naturally air-dried to obtain a PET film with a multi-component composite coagulant coating.
[0140] The effect of this on water vapor and oxygen permeability was investigated, and the results are as follows: Figure 8As shown (the horizontal axis "PET" represents untreated PET film; the horizontal axis "glutenin" represents PET film directly immersed in a 20 mg / mL glutenin solution for 30 min, then air-dried to obtain a PET film with a single glutenin coating; the horizontal axis "glutenin / ε-PL" represents PET film directly immersed in a glutenin / ε-PL two-component composite coagulant for 30 min (glutenin concentration of 20 mg / mL and ε-PL concentration of 4 mg / mL), then air-dried to obtain a PET film with a single glutenin coating); The PET film with a glutenin / ε-PL two-component composite coagulation coating was obtained. The horizontal axis "glutenin / ε-PL / tannic acid" represents the PET film being directly immersed in the glutenin / ε-PL / tannic acid multi-component composite coagulation for 30 minutes (where the glutenin concentration is 20 mg / mL, the ε-PL concentration is 4 mg / mL, and the tannic acid concentration is 0.425 mg / mL). After being removed and air-dried, the PET film with the glutenin / ε-PL / tannic acid multi-component composite coagulation coating was obtained.
[0141] The results showed that the coating formed by glutenin in PET film could improve the water vapor and oxygen permeability of PET film; the water vapor permeability of the glutenin / ε-PL two-component composite coagulated coating was 25.94 g / (m³) compared to that of the glutenin coating. 2 • Increased to 25.07 g / (m²) in 24 hours 2 (24h), compared to PET film, it increased by 21.13%; oxygen permeability increased from 18.56cm compared to glutenin coating. 3 / (m 2 The pressure (0.1 MPa) increased to 18.20 cm over 24 hours. 3 / (m 2 (24h·0.1MPa), which is 8.45% higher than that of PET film.
[0142] The glutenin / ε-PL / tannic acid multi-component composite coagulated coating has a content of 23.31 g / (m³). 2 (24h), compared to PET film, it improved by 29.12%, with an oxygen permeability of 16.06 cm⁻¹. 3 / (m 2 (24h·0.1MPa), which is 19.21% higher than that of PET film.
[0143] In summary, the multi-component composite coagulant coating of glutenin / ε-PL / tannic acid can effectively improve the coating's resistance to water vapor and oxygen permeation, thus significantly enhancing food preservation performance.
[0144] Comparative Example 3: Coatings prepared using different processes
[0145] (1) Reduce the amount of ε-PL used
[0146] Based on Comparative Example 1, a multi-component composite coagulant of glutenin / ε-PL / tannic acid (glutenin concentration of 20 mg / mL; ε-PL concentration of 1 mg / mL; tannic acid concentration of 0.425 mg / mL) was prepared, and its water vapor transmission rate and oxygen transmission rate were tested according to the method of Example 2.
[0147] The results showed that precipitation occurred in the glutenin / ε-PL / tannic acid multicomponent complex coagulation system, and the PET film contained a very small amount of glutenin coating. The water vapor and oxygen permeability were 31.29 g / (m³). 2 ·24h) and 19.64cm 3 / (m 2 (24h·0.1MPa), with no significant difference in performance compared to the PET film itself.
[0148] (2) Change the preparation order
[0149] Based on Comparative Example 2, a multi-component complex coagulated by glutenin / tannic acid / ε-PL was obtained (final concentration of glutenin was 20 mg / mL; final concentration of tannic acid was 0.425 mg / mL; final concentration of ε-PL was 4 mg / mL). Its water vapor transmission rate and oxygen transmission rate were tested according to the method in Example 2.
[0150] The results showed that stratification occurred in the glutenin / tannic acid / ε-PL multi-component composite coagulate system, and the PET film contained a small amount of glutenin / ε-PL coating. Water vapor and oxygen permeability results are as follows: Figure 8 As shown in the glutenin / tannin / ε-PL group, the water vapor and oxygen permeability were 26.29 g / (m²). 2 ·24h) and 19.01cm 3 / (m 2 Although the performance of the coating (24h·0.1MPa) is improved compared to PET film, it is similar to the effect of using only glutenin and glutenin / ε-PL two-component composite coagulant coating.
[0151] Although the present invention has been disclosed above with reference to preferred embodiments, it is not intended to limit the present invention. Anyone skilled in the art can make various modifications and alterations without departing from the spirit and scope of the present invention. Therefore, the scope of protection of the present invention should be determined by the claims.
Claims
1. A multi-component composite coagulant coating based on glutenin, characterized in that, The preparation method of the multi-component composite coagulated coating based on glutenin is as follows: The substrate was immersed in a multi-component composite coagulant solution of glutenin / ε-polylysine / tannic acid to prepare a multi-component composite coagulant coating on the surface of the substrate. The preparation method of the glutenin / ε-polylysine / tannic acid multi-component composite coagulate solution includes the following steps: (1) Mix the glutenin solution with the ε-polylysine solution to obtain a glutenin / ε-polylysine bicomponent composite coagulate solution; wherein the mass ratio of glutenin to ε-polylysine is 1~5:1; (2) Take the glutenin / ε-polylysine two-component composite coagulation solution and add tannic acid solution under stirring conditions of 300~400 rpm to prepare the glutenin / ε-polylysine / tannic acid multi-component composite coagulation solution; wherein, the mass ratio of tannic acid to ε-polylysine is 1:9~47.
2. The multi-component composite coagulant coating based on glutenin according to claim 1, characterized in that, Methods for preparing glutenin solution include: Dissolve glutenin in 0.01-0.05M NaOH solution at a ratio of 0.4-1g:50mL, and stir at 400-600 rpm for 20-40 min. Add an equal volume of PBS buffer and continue stirring for 1-3 h. After stirring, centrifuge at 4000-5000 rpm for 10-20 min, collect the supernatant, and prepare the glutenin solution.
3. The multi-component composite coagulant coating based on glutenin according to claim 1, characterized in that, The pH of glutenin solution is 7-9; the pH of ε-polylysine solution is 6-8; and the pH of tannic acid solution is 6-7.
4. A multi-component complex coagulant based on glutenin, characterized in that, The multi-component complex coagulated based on glutenin is prepared from glutenin, ε-polylysine, and tannic acid, and the preparation method includes: (1) Mix the glutenin solution with the ε-polylysine solution to obtain a glutenin / ε-polylysine bicomponent composite coagulate solution; wherein the mass ratio of glutenin to ε-polylysine is 1~5:1; (2) Take the glutenin / ε-polylysine two-component composite coagulation solution and add tannic acid solution under stirring conditions of 300~400 rpm to prepare a multi-component composite coagulation based on glutenin; wherein the mass ratio of tannic acid to ε-polylysine is 1:9~47.
5. The multi-component complex coagulant based on glutenin according to claim 4, characterized in that, Methods for preparing glutenin solution include: Dissolve glutenin in 0.01-0.05M NaOH solution at a ratio of 0.4-1g:50mL, and stir at 400-600 rpm for 20-40 min. Add an equal volume of PBS buffer and continue stirring for 1-3 h. After stirring, centrifuge at 4000-5000 rpm for 10-20 min, collect the supernatant, and prepare the glutenin solution.
6. The application of the multi-component composite coagulant coating based on glutenin as described in any one of claims 1 to 3 in packaging materials.
7. The application according to claim 6, characterized in that, The packaging materials include: polystyrene, polyethylene, polyvinyl chloride, phenolic resin, urea-formaldehyde resin, epoxy resin, polyester, polyurethane, and polymethyl methacrylate.
8. The application of the multi-component composite aggregate based on glutenin as described in any one of claims 4 to 5 in the preparation of chemical products.
9. The application according to claim 8, characterized in that, The chemical products include: coatings, pigments, additives, and adhesives.
10. The application of the multi-component composite aggregate based on glutenin as described in any one of claims 4 to 5 in the formation of an edible coating on a food surface.
Citation Information
Patent Citations
Preparation method and application of thymol-loaded acylated ovalbumin and epsilon-polylysine composite nanogel
CN117143358A
